iRhythm Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on iRhythm Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how iRhythm Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with iRhythm Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
iRhythm Holdings Inc (iRhythm), formerly iRhythm Technologies Inc, is a digital healthcare company. Its products include Zio Monitor System, a remote ECG monitoring system; Zio ECG Utilization Software System (ZEUS), to support the capture and analysis of ECG data. It also offers a mobile cardiac telemetry (MCT) monitoring system known as Zio AT; ZioSuite, which interprets reports, manages patients, and tracks patient monitors efficiently through a comprehensive web portal and mobile app; and MyZio patient app that helps patients with digital symptom logging, educational content, and reminders. Its products are offered to general cardiologists, electrophysiologists, primary care physicians, neurologists, and other physician specialists through sales representatives, field billing specialists, and customer experience representatives. iRhythm is headquartered in San Francisco, California, the US.
Headquarters
United States of America
Address
699 8th Street, Suite 600, San Francisco, California, 94103
Website
www.irhythmtech.com
Telephone
1 415 6325700
No of Employees
2,400
Industry
Medical Equipment
Ticker Symbol & Exchange
IRTC (NASD)
Revenue (2024)
$747.1M
26.2%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
60.7%
(2024 vs 2023)
Market Cap*
$3.7B
Net Profit Margin (2024)
XYZ
68.9%
(2024 vs 2023)
* As of and is in US$
iRhythm Holdings Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| ECG Utilization Software System | Ambulatory Cardiac Monitoring | Zio |
| Remote ECG Monitoring System | Web Portal | ZioSuite |
| Mobile Cardiac Telemetry (MCG) Monitoring System | Patient Monitoring Application | Zio AT |
| XYZ | ||
| XYZ | ||
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In July, the company entered into a partnership with Lucem Health to leverage predictive AI to help identify arrhythmias earlier in patient populations with a higher risk for arrhythmias. |
| 2025 | New Products/Services | In May, the company launched the Zio Long-Term ECG Monitoring System in Japan. |
| 2024 | Regulatory Approval | In October, the company received clearance from the U.S. Food and Drug Administration for its 510(k) submission related to prior design changes made to the Zio AT device through a letter to file. |
Competitor Comparison
| Key Parameters | iRhythm Holdings Inc | Medtronic Plc | GE HealthCare Technologies Inc | Boston Scientific Corp | BardyDx Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Ireland | United States of America | United States of America | United States of America |
| City | San Francisco | Dublin | Chicago | Marlborough | Seattle |
| State/Province | California | - | Illinois | Massachusetts | Washington |
| No. of Employees | 2,400 | 95,000 | 54,000 | 59,000 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Quentin S. Blackford | Director; President; Chief Executive Officer | Executive Board | 2021 | 47 |
| Daniel G. Wilson | Chief Financial Officer | Senior Management | 2024 | 44 |
| Brian Lawrence, PhD | Executive Vice President; Chief Technology Officer | Senior Management | 2025 | 56 |
| Patrick Murphy | Chief Business Officer; Chief Legal Officer | Senior Management | 2023 | 47 |
| Julie Rodda | Executive Vice President; Chief People Officer; Chief Capability Officer | Senior Management | - | 45 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer